Search Within

Sandra Pierina D'Angelo

Formats
  1. Meeting Abstract (137)
  2. Journal Article (107)
  3. Review (4)
  4. Research Letter (3)
  5. Book Section (1)
  6. Book Whole (1)
  7. Editorial (1)
  8. Guidelines (1)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (256)
  2. Hematologic Malignancies, Division of (256)
  3. Sarcoma Service (256)
  4. Solid Tumor Oncology Division (256)
  5. GSK Faculty (104)
  6. Tow Center for Developmental Oncology (TCDO) (91)

More Groups

People
  1. William Tap (107)
  2. Mark Dickson (86)
  3. Mrinal Gounder (75)
  4. Mary Keohan (73)
  5. Ping Chi (61)
  6. Cristina Antonescu (55)

More People

Years
  1. 2025 (9)
  2. 2024 (19)
  3. 2023 (20)
  4. 2022 (32)
  5. 2021 (16)
  6. 2020 (22)

More Years

Publications
  1. Journal of Clinical Oncology (102)
  2. Journal for ImmunoTherapy of Cancer (24)
  3. Annals of Oncology (16)
  4. Clinical Cancer Research (12)
  5. JAMA Oncology (5)
  6. Journal of Thoracic Oncology (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (104)
  2. Biomed Central Ltd (26)
  3. Oxford University Press (20)
  4. American Association for Cancer Research (19)
  5. Elsevier Inc. (16)
  6. Springer (9)

More Publishers

Results (256)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 3 randomized, open-label study of nivolumab (anti-PD-1; BMS-936558; ONO-4538) versus investigator's choice chemotherapy (ICC) in patients with advanced melanoma after prior anti-CTLA-4 therapy
    Meeting Abstract

    Weber, J. S.; Minor, D. R.; D'Angelo, S. P.; Hodi, F. S.; Gutzmer, R.; Neyns, B.; Hoeller, C.; Khushalani, N. I.; Miller, W. H.; Grob, J. J.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Phase II study of the GI-4000 KRAS vaccine after curative therapy in patients with stage I-III lung adenocarcinoma harboring a KRAS G12C, G12D, or G12V mutation
    Journal Article

    Chaft, J. E.; Litvak, A.; Arcila, M. E.; Patel, P.; D'Angelo, S. P.; Krug, L. M.; Rusch, V.; Mattson, A.; Coeshott, C.; Park, B.; more...
    Clinical Lung Cancer (2014)

    Fulltext@MSK | Save
  • Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: Invasive mucinous pattern and extracellular mucin are associated with KRAS mutation
    Journal Article

    Kadota, K.; Yeh, Y. C.; D'Angelo, S. P.; Moreira, A. L.; Kuk, D.; Sima, C. S.; Riely, G. J.; Arcila, M. E.; Kris, M. G.; Rusch, V. W.; more...
    American Journal of Surgical Pathology (2014)

    Fulltext@MSK | Save
  • Sarcoma immunotherapy: Past approaches and future directions
    Journal Article

    D'Angelo, S. P.; Tap, W. D.; Schwartz, G. K.; Carvajal, R. D.
    Sarcoma (2014)

    Fulltext@MSK | Save
  • A phase Ib/II study of imatinab and everolimus in patients with PDGFRA plus synovial sarcoma
    Meeting Abstract

    Keohan, M. L.; Tap, W. D.; Dickson, M. A.; D'Angelo, S. P.; Carvajal, R. D.; Gounder, M. M.; Morales, R. E.; Condy, M. M.; Hameed, M.; Ho, A. L.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Vemurafenib (VEM) in patients (pts) with BRAF-mutant melanoma and brain metastases (mets)
    Meeting Abstract

    Harding, J. J.; Catalanotti, F.; Yaqubie, A.; McDermott, G. C.; Kersellius, R.; Merghoub, T.; Carvajal, R. D.; D'Angelo, S. P.; Dickson, M. A.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified liposarcoma
    Meeting Abstract

    Dickson, M. A.; Tap, W. D.; Keohan, M. L.; D'Angelo, S. P.; Gounder, M. M.; Chi, P.; Antonescu, C. R.; Landa, J.; Qin, L. X.; Rathbone, D. D.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Alliance A091103: Multicenter phase II study of the angiopoietin-1 and -2 peptibody trebananib for the treatment of angiosarcoma
    Meeting Abstract

    D'Angelo, S. P.; Mahoney, M. R.; Van Tine, B. A.; Adkins, D.; Perdekamp, M. T. G.; Condy, M. M.; Hartley, E.; Antonescu, C. R.; Schwartz, G. K.; Tap, W. D.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Poor prognostic features in angiosarcoma: A single institution retrospective study of 324 patients
    Meeting Abstract

    D'Angelo, S. P.; Moraco, N. H.; Qin, L. X.; Kuk, D.; Carvajal, R. D.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Antonescu, C. R.; Singer, S.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase III open-label study of nivolumab (anti-PD-1; BMS-936558; ONO-4538) versus investigator's choice in advanced melanoma patients progressing post anti-CTLA-4 therapy
    Meeting Abstract

    Chmielowski, B.; Hamid, O.; Minor, D. R.; D'Angelo, S. P.; Pennock, G. K.; Grossmann, K.; Ascierto, P. A.; Daud, A.; Dummer, R.; Hodi, F. S.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save